Search
Patexia Research
Case number 1:22-cv-00746

Pfizer Inc. et al v. MSN Laboratories Private Ltd. > Documents

Date Field Doc. No.Description (Pages)
Jun 22, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [8] STIPULATION TO EXTEND TIME for defendant MSN Laboratories Private Ltd. to answer or otherwise respond to the Complaint (D.I. 1) to August 29, 2022, filed by PF Prism C.V., C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, Pfizer Inc., PF Prism IMB B.V. Reset Answer Deadlines: MSN Laboratories Private Ltd. answer due 8/29/2022. Ordered by Judge Colm F. Connolly on 6/22/2022. (kmd)
Jun 21, 2022 8 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME for defendant MSN Laboratories Private Ltd. to answer or otherwise respond to the Complaint (D.I. 1) to August 29, 2022 - filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF Prism C.V., PF Prism IMB B.V., Pfizer Inc.. (Dellinger, Megan)
Jun 9, 2022 7 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Pfizer Inc., C.P. Pharmaceuticals International C.V., PF Prism C.V., PF Prism IMB B.V., PBG Puerto Rico LLC. MSN Laboratories Private Ltd. served on 6/8/2022, answer due 6/29/2022. (Dellinger, Megan)
Jun 8, 2022 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)
Jun 6, 2022 1 Main Document (12)
Docket Text: COMPLAINT filed against MSN Laboratories Private Ltd. ( Filing fee $ 402, receipt number ADEDC-3890082.) - filed by Pfizer Inc., C.P. Pharmaceuticals International C.V., PF Prism C.V., PF Prism IMB B.V., and PBG Puerto Rico LLC. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(srs)
Jun 6, 2022 1 Exhibit A (17)
Jun 6, 2022 1 Civil Cover Sheet (2)
Jun 6, 2022 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs)
Jun 6, 2022 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: MSN Tablet notification received April 25, 2022. Thirty month stay deadline: October 25, 2024. MSN Oral Solution notification received May 12, 2022. Thirty month stay deadline: November 12, 2024. Date of Expiration of Patent: December 8, 2025. (srs)
Jun 6, 2022 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,783 E. (srs)
Jun 6, 2022 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF Prism C.V., and PF Prism IMB B.V. filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF Prism C.V., PF Prism IMB B.V., Pfizer Inc.. (srs)
Jun 6, 2022 6 Summons Issued (2)
Docket Text: Summons Issued as to MSN Laboratories Private Ltd. on 6/6/2022. (srs)
Jun 6, 2022 1 Complaint* (1)
Menu